Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Video-assisted lobectomy in the elderly

H Asamura1, H Nakayama, H Kondo

  • 1Division of Thoracic Surgery, National Cancer Center Hospital Japan, Cho-ku, Tokyo.

Chest
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.

British journal of cancer·2014
Same author

Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
See all related articles

Video-assisted lobectomy is feasible in elderly patients over 80 with early-stage lung cancer. While successful in 75% of cases, careful patient selection is crucial for optimal outcomes in this age group.

Area of Science:

  • Thoracic Surgery
  • Minimally Invasive Procedures
  • Geriatric Oncology

Background:

  • Video-assisted thoracic surgery (VATS) offers potential advantages for frail patients.
  • Elderly patients with lung cancer present unique surgical challenges.

Purpose of the Study:

  • To evaluate the feasibility of video-assisted lobectomy in patients over 78 years old.
  • To assess the safety and efficacy of VATS lobectomy in a geriatric population.

Main Methods:

  • Eight patients aged 78-85 with early-stage lung cancer underwent attempted VATS lobectomy.
  • Patients had peripheral T1N0 or T2N0 lung carcinomas.

Main Results:

  • Successful VATS lobectomy was achieved in 6 out of 8 patients (75%).

Related Experiment Videos

  • Two patients required conversion to open thoracotomy due to bleeding and adhesions.
  • No operative deaths occurred; prolonged air leakage was observed in two patients.

    • Conclusions:

    • VATS lobectomy is feasible in selected patients over 80 years old.
    • Careful patient selection is essential for successful outcomes.
    • Potential benefits in this age group require further investigation.